LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Clinical data on new and emerging topical AD medications 
  • Data regarding targeted systemic agents for AD 
  • Effects of different AD treatments on clinical symptoms 
  • Evidence on safety and efficacy for targeted oral AD treatments 

• Greater competence related to
  • Selecting AD treatments that consider patient-related factors, such as age, severity, Fitzpatrick skin type, and comorbid conditions
  • Increased confidence in the ability to incorporate  team-based management of dermatologic conditions

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Treatment strategies for individualized management of pediatric dermatologic conditions
  • Data on new and emerging treatments for molluscum contagiosum 

• Greater competence related to
  • Selecting treatments that consider patient-related factors such as age, severity, Fitzpatrick skin type, and comorbid conditions
  • Greater confidence in their ability to engage in team-based management of dermatologic conditions 

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Integration of new and emerging topical psoriasis treatments in care plans across the severity spectrum 
  • Clinical evidence regarding biologic psoriasis treatments
  • Updates on clinical data for targeted oral psoriasis therapies 

  Greater confidence in their

  • Ability to identify team-based roles for managing dermatologic adverse events in patients with psoriasis 

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • New and emerging evidence in topical acne treatments
  • Best practices for antibiotic use in the treatment of acne and rosacea 
  • Current and emerging treatments for hidradenitis suppurativa 
  • Individualized treatment based on patient characteristics such as age, gender, and Fitzpatrick skin type 
• Greater confidence in their ability to
  • Integrate interprofessional team to improve outcomes for patients affected by Hidradenitis suppurativa 

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Clinical evidence on new and emerging treatments for inflammatory dermatologic conditions
  • Pathophysiology underlying inflammatory dermatologic diseases
  • Burden of undertreated and underrecognized dermatologic conditions, such as vitiligo and alopecia areata
  • Burden of undertreated pruritic conditions such as urticaria and prurigo nodularis 
  • Best practices in team-based management of inflammatory dermatologic conditions

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Burden of undertreated hyperhidrosis  
  • Data on new/emerging treatments for dermatologic diseases, such as hyperhidrosis and actinic keratosis
  • Recent changes that have altered dermatologic disease management, such as COVID-19, artificial intelligence, and telemedicine
  • Best practices in team-based management of dermatologic conditions  

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Identification of patients who would be candidates for neuromodulators or fillers in facial aesthetics
  • Role of facial assessment in reducing complications for patients receiving neuromodulators or fillers for facial aesthetic procedures
• Greater competence related to
  • Selecting injection techniques when using neuromodulators or fillers in facial aesthetics

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Aesthetic procedures used to tone, tighten, and lift the skin
  • Treatment modalities used to target the underlying pathophysiology of cellulite
• Greater competence related to
  • Selecting body contouring modalities for patients seeking body work

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Diagnostic methods used to identify patients with cutaneous malignancies 
  • Surgical evaluation of patients with cutaneous malignancies
  • Clinical trial data evaluating treatment regimens for patients with cutaneous malignancies
• Greater competence related to
  • Creating customized care plans for patients with cutaneous malignancies
• Greater confidence in their ability to
  • Coordinate with the interdisciplinary and multidisciplinary teams to manage patients with cutaneous malignancies
  • Incorporate best practices in team-based management of dermatologic conditions

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Treatment strategies for managing psoriasis across a diverse array of patients
  • Individualizing acne treatments based on severity and patient characteristics (age, gender, and Fitzpatrick skin type)
  • Development of individualized skin and haircare regimens for patients of different Fitzpatrick skin types
• Greater competence related to
  • Selecting AD treatments that consider patient-related factors such as age, severity, Fitzpatrick skin type, and comorbid conditions
  • Recommending OTC skincare that is most advantageous for dermatologic conditions in patients with skin of color
• Greater confidence in incorporating best practices in team-based management of dermatologic conditions

LEARNING OBJECTIVES

Upon completion of this session, learners will have

• Increased knowledge regarding the
  • Evidence supporting different OTC products in aiding skin barrier function
  • Role of different sunscreen ingredients in providing photoprotection
  • Application of OTC adjuvants to office-based dermatologic procedures
  • Selection of OTC products as part of skin and hair care regimens for patients for different Fitzpatrick skin types
• Increased confidence in incorporating best practices in team-based management of dermatologic conditions